Cargando…
Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds
BACKGROUND: Schistosomiasis is a neglected tropical disease with high morbidity and mortality in the world. Currently, the treatment of this disease depends almost exclusively on praziquantel (PZQ); however, the emergence of drug resistance to PZQ in schistosomes makes the development of novel drugs...
Autores principales: | Liu, Jian, Dyer, David H, Cheng, Jingdong, Wang, Jipeng, Wang, Shuqi, Yang, Zhong, Wang, Xiaoning, Hu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691639/ https://www.ncbi.nlm.nih.gov/pubmed/23734964 http://dx.doi.org/10.1186/1756-3305-6-162 |
Ejemplares similares
-
3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds
por: Liu, Jian, et al.
Publicado: (2013) -
Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds
por: Pavani, Thaís F. A., et al.
Publicado: (2023) -
Intake of Erythrocytes Required for Reproductive Development of Female Schistosoma japonicum
por: Wang, Jipeng, et al.
Publicado: (2015) -
Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum
por: Song, Li-Jun, et al.
Publicado: (2018) -
An improved genome assembly of the fluke Schistosoma japonicum
por: Luo, Fang, et al.
Publicado: (2019)